| View Larger Image | Process Scale Purification of Antibodies | Hardcoverby Uwe Gottschalk (Author)
| List Price: | $99.95 | | Price: | $79.96 | | You Save: | $19.99 (20%) | | | Available: | Usually ships in 24 hours |
| | Binding: | Hardcover | | Publisher: | Wiley-Interscience | | Edition: | 1st Edition | | Page Count: | 434 Pages | | Publication Date: | February 09, 2009 | | Sales Rank: | 81,501st |
|
EDITORIAL REVIEWS |
Product Description
Traditional column chromatography dominates current purification technology, and many of the productivity gains that have been achieved have relied on upscaling such devices. However, this comes with a cost penalty and the pharmaceutical industry has reached the point at which further upscaling becomes economically unsupportable. This book offers a broad-based reassessment of old and new purification methods, incorporating an analysis of innovative new trends in purification. The book has wide coverage of different antibody purification strategies and brings together top-tier experts to address problems in process-scale antibody purification. |
SIMILAR PRODUCTS |
| Cell Culture Technology for Pharmaceutical and Cell-Based Therapies (Biotechnology and Bioprocessing Series)
by Sadettin Ozturk (Editor), Wei-Shou Hu (Editor)
Edited by two of the most distinguished pioneers in genetic manipulation and bioprocess technology, this bestselling reference presents a comprehensive overview of current cell culture technology used in the pharmaceutical industry. Contributions from several leading researchers showcase the importance of gene discovery and genomic technology development in the production of biotechnology products, tissue engineering, and cell-based therapies. Offering detailed guidance, they cover the steps...
| 
| Cell Culture and Upstream Processing
by Mike Butler (Author)
Upstream processing refers to the production of proteins by cells genetically engineered to contain the human gene which will express the protein of interest. The demand for large quantities of specific proteins is increasing the pressure to boost cell culture productivity, and optimizing bioreactor output has become a primary concern for most pharmaceutical companies. Each chapter in Cell Culture and Upstream Processing is taken from presentations at the highly acclaimed IBC conferences as...
| 
| Handbook of Process Chromatography, Second Edition: Development, Manufacturing, Validation and Economics
by Lars Hagel (Author), Günter Jagschies (Author), Gail K. Sofer (Author)
This book will update the original edition published in 1997. Since the publication of the first edition, the biotechnology and biologics industries have gained extensive knowledge and experience in downstream processing using chromatography and other technologies associated with recovery and purification unit operations. This book will tie that experience together for the next generation of readers.
Updates include:
- sources and productivity
- types of products made...
| 
| Process Scale Bioseparations for the Biopharmaceutical Industry (Biotechnology and Bioprocessing Series)
by Abhinav A. Shukla (Editor), Mark R. Etzel (Editor), Shishir Gadam (Editor)
The biopharmaceutical industry has become an increasingly important player in the global economy, and the success of these products depends on the development and implementation of cost-effective, robust and scaleable production processes. Bioseparations-also called downstream processing- can be a key source of competitive advantageto biopharmaceutical developers. Process Scale Bioseparations for the Biopharmaceutical Industry brings together scientific principles, empirical approaches, and...
| 
| Quality by Design for Biopharmaceuticals: Principles and Case Studies (Wiley Series in Biotechnology and Bioengineering)
by Anurag S. Rathore (Editor), Rohin Mhatre (Editor)
The concepts, applications, and practical issues of Quality by Design Quality by Design (QbD) is a new framework currently being implemented by the FDA, as well as EU and Japanese regulatory agencies, to ensure better understanding of the process so as to yield a consistent and high-quality pharmaceutical product. QbD breaks from past approaches in assuming that drug quality cannot be tested into products; rather, it must be built into every step of the product creation...
|
|
|
